secwatch / observer
8-K filed January 31, 2022, 6:59 PM ET ticker SRTS CIK 0001494891
leadership confidence high sentiment neutral materiality 0.50

Sensus Healthcare elects Michael Sardano as President; Joseph Sardano remains Chairman and CEO

Sensus Healthcare, Inc.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Joseph C. Sardano

President
SRTS · Sensus Healthcare, Inc.
Effective
2022-01-27
Successor
Michael J. Sardano
Filed
January 31, 2022, 6:59 PM ET
In connection with the election of Michael Sardano, Joseph C. Sardano, Chairman, President, and Chief Executive Officer of Sensus Healthcare, Inc. (the “Company”), resigned as President, effective January 27, 2022.
Departed

Stephen Cohen

Executive Vice President, Strategic Initiatives and Dermatology
SRTS · Sensus Healthcare, Inc.
Effective
2022-01-28
Filed
January 31, 2022, 6:59 PM ET
Effective January 28, 2022, Stephen Cohen, Executive Vice President, Strategic Initiatives and Dermatology, of the Company, resigned.
Role change

Michael J. Sardano

President
SRTS · Sensus Healthcare, Inc.
Effective
2022-01-27
Filed
January 31, 2022, 6:59 PM ET
On January 27, 2022, Michael J. Sardano was elected President of the Company, to serve until the next annual meeting of the Company’s Board of Directors, subject to his earlier resignation, removal, or death.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Joseph C. Sardano resigned as President at Sensus Healthcare, Inc..

Action
resigned
Role
President
Exact text from the filing
In connection with the election of Michael Sardano, Joseph C. Sardano, Chairman, President, and Chief Executive Officer of Sensus Healthcare, Inc. (the “Company”), resigned as President, effective January 27, 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Stephen Cohen resigned as Executive Vice President, Strategic Initiatives and Dermatology at Sensus Healthcare, Inc..

Action
resigned
Role
Executive Vice President, Strategic Initiatives and Dermatology
Exact text from the filing
Effective January 28, 2022, Stephen Cohen, Executive Vice President, Strategic Initiatives and Dermatology, of the Company, resigned.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Michael J. Sardano was elected as President at Sensus Healthcare, Inc..

Action
elected
Role
President
Exact text from the filing
On January 27, 2022, Michael J. Sardano was elected President of the Company, to serve until the next annual meeting of the Company’s Board of Directors, subject to his earlier resignation, removal, or death.
View on SEC.gov

Sensus Healthcare, Inc. filing history →

Source: SEC EDGAR
accession 0001213900-22-004504
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.